EHS
EHS

STAT Plus: A CAR-T bottleneck: Centers that collect patient cells feel crunch from growing demand

The arrival of CAR-T cancer treatments and the expected coming age of cell therapies are opening new frontiers for what medicines look like: Cells are taken from patients, then tweaked or supercharged in a lab, and finally given back to patients.

But the emergence of those treatments has put a pinch on the places that collect those cells from patients. The crunch is only expected to grow as more CAR-T candidates and other cell therapies enter clinical trials and win approval.

Continue to STAT Plus to read the full story…

EHS
Back to top button